Tech Mahindra and NVIDIA Launch AI-Powered Pharmacovigilance Solution

Tech Mahindra has announced a new pharmacovigilance solution developed in collaboration with NVIDIA, announced in a press release. This AI-powered solution aims to improve drug safety management by leveraging agentic AI and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes.

The solution is built on Tech Mahindra's TENO framework, which integrates NVIDIA's AI technology, including the NVIDIA AI Enterprise software platform. This integration streamlines various pharmacovigilance workflows such as case intake, data transformation, quality control, and compliance management. The AI agents within the solution autonomously handle tasks like case classification and prioritization, significantly reducing the risk of human error.

By automating these processes, the solution reduces turnaround times by up to 40%, enhances data accuracy by 30%, and cuts operational costs by 25%. This ensures timely case processing and regulatory adherence, transforming pharmacovigilance from a reactive to a predictive approach. The collaboration between Tech Mahindra and NVIDIA aims to provide better patient outcomes by bringing AI-driven intelligence to pharmacovigilance.